Impact Of Asthma Screenings Blocked by Nonadherence
An American Thoracic Society workshop reports that while population screenings make sense in theory, the benefits are unproven for children with asthma.
According to Lynn Gerald, Ph.D., M.S.P.H., workshop co-chair,
Commentary
I’ve focused on this concern that noncompliance blocks implementation of clinical action when screenings detect possible pathology because it spotlights a hidden cost of nonadherence.
It is an often overlooked albeit obvious fact that the time, human resources, and money expended to discover a case of untreated asthma – or any other disease – are lost unless the that patient pursues clinical confirmation of the disorder and any necessary treatment.
The reality of noncompliance is crystallized in Dr. Gerald’s recommendation that the limited resources of public health should be used for children with active symptomatology rather than screenings.
Source:News-Medical.Net